Covington & Burling

TriSalus Life Sciences Secures up to $50 million of Debt Financing with OrbiMed to Support TriNav® Infusion System Growth Initiatives

Retrieved on: 
화요일, 4월 30, 2024
Research, Other Health, Professional Services, Pharmaceutical, Oncology, Medical Devices, Clinical Trials, Science, Other Professional Services, Biotechnology, Finance, Health, Other Science, LLP, Covington & Burling, OrbiMed, Therapy, Liver, General partnership, Cooley LLP, Credit, Growth

TriSalus Life Sciences Inc., (Nasdaq: TLSI), today announced the closing of a debt financing facility for up to $50 million with OrbiMed, a healthcare investment firm.

Key Points: 
  • TriSalus Life Sciences Inc., (Nasdaq: TLSI), today announced the closing of a debt financing facility for up to $50 million with OrbiMed, a healthcare investment firm.
  • The capital is expected to provide financial flexibility to support the execution of strategic expansion plans and fuel continued growth.
  • Under the terms of the Credit Agreement (the “Credit Agreement”) with OrbiMed, the Company borrowed $25 million at closing.
  • “We are excited to be partnering with OrbiMed,” said Mary Szela, Chief Executive Officer of TriSalus Life Sciences.

Incyte Announces Acquisition of Escient Pharmaceuticals and its Pipeline of First-in-Class Oral MRGPR Antagonists

Retrieved on: 
화요일, 4월 23, 2024
Biotechnology, General Health, Other Health, Health, Pharmaceutical, Goldman Sachs, American Academy, Hart–Scott–Rodino Antitrust Improvements Act, B cell, LLP, Safety, Skin, Vital signs, Centerview Partners, Research, ECG, Covington & Burling, MRGPRX2, MRGPRX4, Autoimmunity, Therapy, Science, Escient, Incidence, Patient, Acquisition, Multimedia, Atopic dermatitis, CSU

This acquisition builds on our strategy to develop differentiated and first-in-class medicines with high potential,” said Hervé Hoppenot, Chief Executive Officer, Incyte.

Key Points: 
  • This acquisition builds on our strategy to develop differentiated and first-in-class medicines with high potential,” said Hervé Hoppenot, Chief Executive Officer, Incyte.
  • “These drug candidates are the result of the highly innovative research performed by Escient’s employees and scientific collaborators,” said Joshua A. Grass, President and Chief Executive Officer, Escient.
  • Centerview Partners LLC and Goldman Sachs & Co. LLC advised Escient on the transaction and Fenwick & West LLP acted as legal counsel for Escient.
  • The replay dial-in number for the United States is 877-660-6853 and the dial-in number for international callers is +1 201-612-7415.

Trustmark Announces Agreement to Sell Fisher Brown Bottrell Insurance, Inc. to Marsh & McLennan Agency LLC

Retrieved on: 
화요일, 4월 23, 2024
Banking, Professional Services, Insurance, Finance, Sale, KPMG, Life, Covington & Burling, Risk management, Culture, National bank, Growth, Real estate

Trustmark National Bank today announced that it has entered into a definitive agreement to sell its wholly owned subsidiary, Fisher Brown Bottrell Insurance, Inc., (“FBBINSURANCE”) to Marsh & McLennan Agency LLC for $345 million in cash.

Key Points: 
  • Trustmark National Bank today announced that it has entered into a definitive agreement to sell its wholly owned subsidiary, Fisher Brown Bottrell Insurance, Inc., (“FBBINSURANCE”) to Marsh & McLennan Agency LLC for $345 million in cash.
  • Duane A. Dewey, President and CEO of Trustmark, stated, “Trustmark entered the insurance brokerage business 25 years ago.
  • In connection with the sale, current leadership and employees of FBBINSURANCE are expected to join Marsh McLennan Agency.
  • Morgan Stanley & Co. LLC and KPMG served as financial advisors and Covington & Burling LLP and Brunini, Grantham, Grower & Hewes PLLC served as legal counsel to Trustmark.

MidFirst Bank to Acquire Houston Banking Locations of Amerant Bank

Retrieved on: 
수요일, 4월 17, 2024
Personal Finance, Finance, Banking, Professional Services, Asset Management, LLP, MidFirst Bank, Covington & Burling, Culture, Acquisition, Growth, Bank

MidFirst Bank ("MidFirst" or the “Company”), the largest privately owned bank in the nation, has entered into a definitive agreement to acquire the Houston, Texas banking locations of Amerant Bank, the main subsidiary of Amerant Bancorp Inc. (NYSE: AMTB).

Key Points: 
  • MidFirst Bank ("MidFirst" or the “Company”), the largest privately owned bank in the nation, has entered into a definitive agreement to acquire the Houston, Texas banking locations of Amerant Bank, the main subsidiary of Amerant Bancorp Inc. (NYSE: AMTB).
  • “Houston is a strategic market for us and the acquisition of Amerant Bank’s Houston locations supports our growth plans,” said MidFirst Bank Chairman and CEO Jeff Records.
  • MidFirst Bank Houston Market Executive Brian Heflin added, “The Amerant Bank team has built a strong reputation in Houston and shares our commitment to customer service and supporting the communities we serve.
  • We look forward to welcoming the Amerant Houston team and their clients to MidFirst, and having the opportunity to demonstrate the quality of the banking services and culture of MidFirst.”
    Upon completion of the transaction, Amerant Bank locations will be operated as MidFirst Bank locations.

Amerant Bancorp Inc. Announces Sale of Texas Operations

Retrieved on: 
수요일, 4월 17, 2024
Banking, Asset Management, Professional Services, Finance, LLP, MidFirst Bank, Webcast, Covington & Burling, Growth, Strategic planning, Management

Amerant Bancorp Inc. (NYSE: AMTB) (“Amerant” or the “Company”) today announced that its wholly owned subsidiary, Amerant Bank, N.A., entered into a definitive purchase and assumption agreement under which MidFirst Bank, based in Oklahoma City, Oklahoma, will acquire Amerant Bank’s banking operations and six branches in the Houston, Texas metropolitan area.

Key Points: 
  • Amerant Bancorp Inc. (NYSE: AMTB) (“Amerant” or the “Company”) today announced that its wholly owned subsidiary, Amerant Bank, N.A., entered into a definitive purchase and assumption agreement under which MidFirst Bank, based in Oklahoma City, Oklahoma, will acquire Amerant Bank’s banking operations and six branches in the Houston, Texas metropolitan area.
  • “As part of our strategic planning process, we reviewed our current business model of operating in both Florida and Texas.
  • Stephens Inc. served as financial adviser and Squire Patton Boggs (US) LLP provided legal counsel to Amerant.
  • Raymond James & Associates, Inc. served as financial adviser and Covington & Burling LLP provided legal counsel to MidFirst Bank.

Bristol Myers Squibb Completes Acquisition of Karuna Therapeutics, Strengthening Neuroscience Portfolio

Retrieved on: 
월요일, 3월 18, 2024
Mental Health, Health, Neurology, Clinical Trials, Pharmaceutical, Biotechnology, BMY, Psychosis, Bristol Myers Squibb, Citigroup, Growth, Schizophrenia, Goldman Sachs, KarXT, EPS, Patient, Simpson Thacher & Bartlett, Acquisition, BMS, LLP, Therapy, GAAP, Covington & Burling, Bipolar I disorder, PDUFA, Pharmaceutical industry

Bristol Myers Squibb (NYSE: BMY) today announced that it has successfully completed its acquisition of Karuna Therapeutics, Inc. (“Karuna”).

Key Points: 
  • Bristol Myers Squibb (NYSE: BMY) today announced that it has successfully completed its acquisition of Karuna Therapeutics, Inc. (“Karuna”).
  • With the acquisition's completion, Karuna shares have ceased trading on the Nasdaq Global Select Market and Karuna is now a wholly owned subsidiary of Bristol Myers Squibb (“BMS”).
  • “We are excited to expand our neuroscience portfolio as we welcome Karuna to Bristol Myers Squibb,” said Chris Boerner, Ph.D., Chief Executive Officer, Bristol Myers Squibb.
  • Bristol Myers Squibb expects to offset the operational expenses of the transaction through continued disciplined resource allocation, cost efficiencies and portfolio prioritization.

Ronald Hewitt Joins Seward & Kissel’s Global Banking and Corporate Trust Group

Retrieved on: 
월요일, 3월 18, 2024
Finance, Consulting, Banking, Professional Services, Legal, Government, Russell Johnston, Private, Seward & Kissel, King & Spalding, University, Lawsuit, Kirkland & Ellis, Covington & Burling, Trustee, Multimedia, Kelley Drye & Warren

Seward & Kissel LLP announced today that Ronald A. Hewitt , formerly with Covington & Burling LLP, has joined the firm’s New York office as a partner in the Global Banking and Corporate Trust Group .

Key Points: 
  • Seward & Kissel LLP announced today that Ronald A. Hewitt , formerly with Covington & Burling LLP, has joined the firm’s New York office as a partner in the Global Banking and Corporate Trust Group .
  • View the full release here: https://www.businesswire.com/news/home/20240318527179/en/
    Ronald Hewitt Joins Seward & Kissel’s Global Banking and Corporate Trust Group (Photo: Business Wire)
    In a tenure spanning nearly two decades at Covington, Hewitt represented institutional clients in all aspects of finance, corporate restructuring, capital markets, and derivative transactions, as well as related regulatory compliance.
  • “Ron’s breadth of expertise in non-distressed and distressed financial transactions immediately strengthens our team in the Global Banking and Corporate Trust Group,” said Jim Cofer , managing partner of Seward & Kissel.
  • “Ron’s commercial approach to solving complex issues and his focus on delivering elite client service squarely align with the group’s core values,” added Gregg Bateman , head of Seward & Kissel’s Global Banking and Corporate Trust Group.

Bristol Myers Squibb Completes Acquisition of PureTech's Founded Entity Karuna Therapeutics for $14 Billion

Retrieved on: 
월요일, 3월 18, 2024
Mental Health, Health, Neurology, Clinical Trials, Pharmaceutical, Biotechnology, BMY, Psychosis, Bristol Myers Squibb, Citigroup, Growth, Schizophrenia, KarXT, Goldman Sachs, EPS, Patient, Neuroscience, Simpson Thacher & Bartlett, Acquisition, BMS, LLP, PRTC, Therapy, GAAP, Covington & Burling, Psychiatry, Bipolar I disorder, PDUFA, Pharmaceutical industry

The full text of the announcement from Bristol Myers Squibb is as follows:

Key Points: 
  • The full text of the announcement from Bristol Myers Squibb is as follows:
    Bristol Myers Squibb Completes Acquisition of Karuna Therapeutics, Strengthening Neuroscience
    PRINCETON, N.J.-- Bristol Myers Squibb (NYSE: BMY) today announced that it has successfully completed its acquisition of Karuna Therapeutics, Inc. (“Karuna”).
  • With the acquisition's completion, Karuna shares have ceased trading on the Nasdaq Global Select Market and Karuna is now a wholly owned subsidiary of Bristol Myers Squibb (“BMS”).
  • “We are excited to expand our neuroscience portfolio as we welcome Karuna to Bristol Myers Squibb,” said Chris Boerner, Ph.D., Chief Executive Officer, Bristol Myers Squibb.
  • Gordon Dyal & Co. and Citi are serving as financial advisors to Bristol Myers Squibb, and Covington & Burling LLP is serving as legal counsel.

Masdar to Acquire 50% Stake in Terra-Gen from Energy Capital Partners

Retrieved on: 
화요일, 3월 19, 2024
PJSC, Nicknames of Houston, ECP, Growth, White, Partnership, White & Case, JPMorgan Chase, LLP, Guggenheim, Wind, BMO Capital Markets, Covington & Burling, Latham & Watkins, Renewable energy

ECP, a leading investor across energy transition, electrification and decarbonization infrastructure assets, will fully exit its position in Terra-Gen in connection with the transaction.

Key Points: 
  • ECP, a leading investor across energy transition, electrification and decarbonization infrastructure assets, will fully exit its position in Terra-Gen in connection with the transaction.
  • Igneo Infrastructure Partners ("Igneo"), a global infrastructure investment manager, will retain its existing 50 percent stake in the company.
  • This transaction unites one of the largest independent renewable energy producers in the U.S. with Masdar – one of the fastest growing clean energy companies in the world.
  • John DiMarco, Managing Director at Igneo, said, "Igneo is excited to partner with Masdar on Terra-Gen's next phase of growth.

Reliance and Disney Announce Strategic Joint Venture to Bring Together the Most Compelling and Engaging Entertainment Brands in India

Retrieved on: 
수요일, 2월 28, 2024
Entertainment, Technology, Film & Motion Pictures, TV and Radio, Mobile Entertainment, Telecommunications, Licensing (Entertainment), Bodhi, Slate, Viacom, Television, Disney Star, AZB, Star Sports, Covington & Burling, Fairness opinion, Digital, Sport, Chairperson, Khaitan & Co, Reliance Industries, StarPlus, Digital India, RIL, JV, Ernst & Young, Citigroup, Goldman Sachs, BDO, HSBC, Film industry

Post completion of the above steps, the JV will be controlled by RIL and owned 16.34% by RIL, 46.82% by Viacom18 and 36.84% by Disney.

Key Points: 
  • Post completion of the above steps, the JV will be controlled by RIL and owned 16.34% by RIL, 46.82% by Viacom18 and 36.84% by Disney.
  • Disney may also contribute certain additional media assets to the JV, subject to regulatory and third-party approvals.
  • The JV will be one of the leading TV and digital streaming platforms for entertainment and sports content in India, bringing together iconic media assets across entertainment (e.g.
  • Cleary Gottlieb served as lead outside counsel to Disney and Covington & Burling and AZB served as legal counsels to Disney on the transaction.